• Piezo Therapeutics uses a proprietary platform combining electric pulses and microneedles for nucleic acid delivery.
  • The platform offers cost-effective, scalable manufacturing, and enhances the safety and efficacy of RNA/DNA medicines.
  • Studies show Piezo's system significantly improves gene expression and immune responses with lower doses, reducing potential adverse reactions.

The rise of mRNA vaccines is changing the face of modern medicine, especially concerning events like pandemics such as COVID-19.

However, a major hurdle for current delivery systems like lipids nanoparticles is the challenges that stare them in the face.

Such techniques often incur high costs of manufacturing, scalability complexities, and potential reactogenicity which might lead to adverse effects and patient noncompliance.

This means that new delivery approaches have to be developed that give priority to safety, efficacy, and availability when demand for RNA- and DNA-based therapies grows.

Piezo Therapeutics – An Introduction

Formed in 2022 from intellectual property developed at Georgia Tech by a team of experts, Piezo Therapeutics is a proprietary platform that combines electric pulses with microneedles.

This results in a delivery system that is not only effective but also cost-efficient and scalable. It is an absolute game changer in my opinion.

Delivery Systems Pioneers

Ultimately, at the core of Piezo’s platform is its ability to provide lasting expression of therapeutic agents while abating some problems associated with traditional delivery methods. Some key benefits are conferred by this ingenious technology:

  • Cost-effective Manufacturing: A simple platform such as Piezo’s makes it possible for one to produce these drugs cheaply hence companies can begin making them available all over the world.
  • Enhanced Safety and Efficacy: New pieces of evidence suggest that Piezo’s system can boost gene expression enormously but generate similar immune responses even at lower doses thereby reducing chances for any unwanted reactions. Think about what this means in terms of patient security!
  • Broad Applicability: The versatility with which it can be used makes it a solution for many types of therapies including vaccines and immunotherapies because large complex payloads are easily accommodated on the platform.

Meet Piezos Visionaries

It was co-founded by Gaurav Byagathvalli, Mark R Prausnitz, Saad Bhamla and Cynthia Sundell each of whom has vast experience in drug delivery and commercialization.

Byagathvalli, a co-inventor of the platform, is an expert in vaccine delivery and synthetic biology.

Prausnitz has conducted extensive research on novel drug delivery technologies such as microneedles, having authored over 320 scientific papers.

The team also includes Bhamla, an innovator in frugal science, and Sundell, a specialist in life sciences commercialization to provide a solid foundation for Piezo’s mission.

To me, this is what makes Piezo Therapeutics so interesting – that these brilliant minds have come together with one goal in mind.

They are about to make RNA- and DNA medicines safer, cheaper, and more accessible with wide implications across the world.

With growing demand for effective nucleic acid delivery systems, Piezo Therapeutics takes the lead in this transformative industry.

Edited By Annette George